J-WAVES AND CARDIAC BIOMARKERS ARE ASSOCIATED WITH LONG-TERM CARDIOVASCULAR OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS
Highlights We propose serum biomarkers as risk assessment tools for patients with COVID-19. J-waves are a common ECG finding, detected in 4–6% of the population, and are a risk factor for ventricular tachycardia and mortality in COVID-19 patients. Aim. To evaluate the prognostic potential of a combination of cardiac-specific biomarkers and ECG J-waves regarding long-term mortality and cardiovascular complications after discharge in patients with COVID-19-associated pneumonia. Methods . Serum biomarkers sST2, VCAM-1 and hs-TnI were assessed at admission in 254 patients hospitalized with COVID-19-associated pneumonia. ECGs on admission were analyzed for the presence of J waves. Clinical and laboratory characteristics of patients, as well as biomarker concentrations and the presence of J-waves on the ECG, were correlated with mortality and cardiovascular complications after discharge at 12 months [FU: 347 (310, 449) days]. Cox proportional hazards models were used to identify predictors of the risk of mortality and the composite endpoint up to one year after discharge. Results . A high level of VCAM-1 was a significant predictor of the risk of a combined endpoint (MI, stroke, pulmonary embolism, sudden death): HR = 1.049, CI 95%: 1.016–1.083; and high sST2 level was a significant predictor of the risk of both death (HR = 1.006, CI 95%: 1.004–1.007) and the composite endpoint (HR = 1.005, CI 95%: 1.003–1.006). In the generalized multivariate model, when other influencing factors were combined, the presence of a J-wave on the ECG during hospitalization was statistically insignificant (p > 0.5) for predicting sudden death up to a year after discharge. Conclusion . In hospitalized COVID-19 survivors, elevated hsTnI and sST2 levels on admission were strong predictors of CV events during long-term follow-up. On the other hand, the significance of the J-wave on the ECG in predicting long-term CV events remains borderline.
Authors
- Irina Alexandrovna Lakman (ORCID: https://orcid.org/0000-0001-9876-9202)
- Д. Ф. Гареева (ORCID: https://orcid.org/0000-0002-1874-8661)
- Н. Ш. Загидуллин (ORCID: https://orcid.org/0000-0003-2386-6707)
- Venera Timiryanova (ORCID: https://orcid.org/0000-0002-1004-0722)
- L.F. Sadikova (ORCID: https://orcid.org/0000-0001-9250-5548)
- A. A. Agapitov (ORCID: https://orcid.org/0000-0002-3618-2657)
Institutions
- University of Science and Technology (YE)
- Bashkir State Medical University (RU)
- Korea University of Science and Technology (KR)
Publication Details
- Journal
- Complex Issues of Cardiovascular Diseases
- Published
- 2024-11-01
- DOI
- https://doi.org/10.17802/2306-1278-2024-13-3s-16-26
- Primary Topic
- Heart Rate Variability and Autonomic Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00